Navigation Links
Sangamo BioSciences and Collaborators Present Data in Fifteen Presentations Highlighting Broad Therapeutic Applications of ZFP Technology
Date:5/24/2010

expectations. These forward-looking statements include, without limitation, the research and development of novel ZFP TFs and ZFNs as ZFP Therapeutics and therapeutic applications of Sangamo's ZFP technology platform to specific human diseases. Actual results may differ materially from these forward-looking statements due to a number of factors, including uncertainties relating to whether clinical trials will validate and support tolerability and efficacy of ZFP Therapeutic approaches, technological challenges, Sangamo's ability to develop commercially viable products and technological developments by our competitors. See Sangamo's SEC filings, and in particular, the risk factors described in the Company's Annual Report on Form 10-K and most recent Quarterly Report on Form 10-Q. Sangamo BioSciences, Inc. assumes no obligation to update the forward-looking information contained in this press release.


'/>"/>
SOURCE Sangamo BioSciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences
2. Sangamo BioSciences Announces Presentation at Cowen and Company Health Care Conference
3. Sangamo BioSciences Reports Fourth Quarter and Full Year 2009 Financial Results
4. Sangamo BioSciences Announces Presentation at BIO CEO & Investor Conference
5. Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS
6. Sangamo BioSciences Announces Presentation at Merriman Curhan Fords Investor Summit 2009
7. Sangamo BioSciences Announces Third Quarter 2009 Conference Call and Webcast
8. Sangamo Announces Pricing of Public Offering of Common Stock
9. Sigma-Aldrich(R) and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement
10. Sangamo BioSciences Announces Presentation at the UBS Global Life Sciences Conference
11. Sangamos Zinc Finger Nuclease Technology Used to Efficiently Modify Human Stem Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014  Next month, executives from clinical trial marketing firm ... beginning with Patient-Centered Clinical Trials 2014 , to be ... , September 4-5. Patient recruitment experts Bonnie A. ... will share insights on the benefits of employing an ... – from media to mobile apps – can be used ...
(Date:8/28/2014)... , Aug. 28, 2014  Armetheon, Inc. ( ... novel mid- to late-stage cardiovascular drug candidates, today ... its first round of financing. The Series A ... Hercules Bioventures with participation from investors that included ... executive, Dr. Larry Hsu , the founder ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 A ... around the world is available from Strategic Consulting, ... companies. “ Industrial Microbiology Market Review, Fourth Edition: ... Market ” (IMMR—4) tracks and compares microbiology test ... North America, Europe and Asia, and forecasts future ...
(Date:8/28/2014)... CA (PRWEB) August 28, 2014 ... is offering a promotion for Eppendorf Safe ... customers to purchase the highest quality tubes at ... are ideal for customers doing chemical, medical, pharmaceutical, ... technicians who are not regularly able to afford ...
Breaking Biology Technology:BBK Worldwide Leads Sessions at Key September Events 2Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 32 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 3Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 2Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 3
... EDMONTON, April 22 /PRNewswire-FirstCall/ - Quest PharmaTech ... announce that it will receive,generous support from ... (SDT) for oncology applications., Sonodynamic Therapy ... in,Hypocrellin-based photodynamic therapy for oncology and skin ...
... $250,000 under March ... ... BMRX), a leading developer and supplier of consumer-based,finger-activated products, today announced ... personnel of Sequiam,Corporation (OTC Bulletin Board: SQUME) through a previously announced,agreement ...
... Conn., April 22 Rib-X Pharmaceuticals, Inc.,("Rib-X" ... on the,discovery and development of novel antibiotics ... that Graham Johnson,Ph.D., Chief Research Officer and ... Cambridge Healthtech Institute,s 2nd Annual "The,Challenge of ...
Cached Biology Technology:Quest PharmaTech Receives Support from National Research Council's Industrial Research Assistance Program (NRC-IRAP) to develop Ultrasound Technology for the Treatment of Cancer 2bioMETRX, Inc. Initiates Integration of Personnel and Assets of Sequiam Corp. 2Rib-X Pharmaceuticals to Present at Cambridge Healthtech Institute's 2nd Annual Challenge of Antibacterial Development Conference 2
(Date:8/29/2014)... type and number of connections in transcription factor networks ... in a study published in PLOS Computational Biology ... assortativity signature contributes to a network,s resilience against mutations. ... out-out assortativity of TFN models has a greater effect ... types of assortativity," said Dov A. Pechenick, PhD, lead ...
(Date:8/29/2014)... twist them, fold them: modern materials that are light, ... as artificial skin or electronic paper. , Making such ... but a new way of working with copper nanowires ... , Previous success in the field of ultra-lightweight ... precious gold and silver nanowires. , By turning ...
(Date:8/28/2014)... an expansion of marine protected areas is needed to ... According to investigators from the Wildlife Conservation Society and ... on saving the largest numbers of species, often at ... difficult-to-replace ecological functions. , Many vital ecological ... that also are food for millions of people. ...
Breaking Biology News(10 mins):Assortativity signatures of transcription factor networks contribute to robustness 2Copper shines as flexible conductor 2Study finds marine protected areas inadequate for protecting fish and ocean ecology 2
... EUGENE, Ore. -- Using new optical equipment, a ... of virtual reality, monitored both their behavior and brain ... brain operates as it moves. The new research ... Scientific Instrumentation Inc. (ASI) -- should help neuroscientists around ...
... largest celebration of science and engineering, the USA ... D.C., April 28-29, 2012. For the second year, ... hands-on experiments. At Carnegie,s booth last year, visitors ... produced by our high pressure lab, touched the ...
... organisms, germ cells give rise to gametes and serve ... germ cell development is the decision to leave mitosis ... eggs and sperm. Germ cell development involves unique gene ... ensure success during fertilization and embryo development. Written ...
Cached Biology News:Worm-tracking challenge leads to new tool for brain research 2Worm-tracking challenge leads to new tool for brain research 3Carnegie partners with USA Science & Engineering Festival for second year 2Carnegie partners with USA Science & Engineering Festival for second year 3
albumin from bovine serum (BSA), BODIPY® FL conjugate...
Full service including gene cloning, protien expression and purification of 1 liter culture....
albumin from bovine serum (BSA), fluorescein conjugate...
GOAT ANTI HUMAN PARAINFLUENZA VIRUS 2+3...
Biology Products: